TromboneAl
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
- Joined
- Jun 30, 2006
- Messages
- 12,880
Yes, they do sound like individual differences, because they are. But in the end, you either believe in quality evidence (it's not all high quality to be sure) or you don't.This dispersion in results makes me very wary about the recent health reform fad of "don't fund what doesn't work?" Doesn't work for whom? Obviously, for some of the reviewers it did nothing, for some others and me and helped a lot. This sounds like individual differences.
I hesitate to answer this because you are a doctor. But in this case we are talking more about logic than clinical medicine, so I'll go ahead. I agree with what you are saying about putting lipstick on the pig by using relative risk reduction to describe postitive results. Many consumers wouldn't have a clue about the distinction you are drawing, but clearly it is very important.Yes, they do sound like individual differences, because they are. But in the end, you either believe in quality evidence (it's not all high quality to be sure) or you don't.
Consider a disease with two treatments. The first treatment cures 80% of those who take the pill and fails to cure 20%. The indistinguishable placebo group noted a cure rate of 70%, with the other 30% not cured.
If you are in the cured, real treatment group you are happy. If you are in the cured placebo group you are happy.
If you are in the cured placebo group, you might conclude the drug worked for you and that this is an individual difference. But in fact, the evidence shows otherwise.
Similarly, the real pill cured group had a higher cure rate, but only 10% better than the placebo group. So the drug works, but not dramatically. Throw in an 8% incidence of side-effects of comparable severity and it's not a clear cut decision to treat.
Like investing, clinical research is all about the margins. Drug companies exploit the evidence by pointing to relative risk reduction rather than absolute reduction and in many other ways (particularly misleading in prevention where the disease isn't that likely to begin with).
You might want to be aware that Hyzaar contains not only the angiotensin receptor blocker losartan (an "ARB") but also a small dose of the diuretic hydrochlorothiazide. Cozaar (losartan alone) does not contain the diuretic. ARBs do not cause the cough that ACEs cause and are comparably effective.A few years ago my BP which had always been low started creeping up, first into borderline hypertension then into Stage I hypertension.
My doc put me on generic lisinopril (really inexpensive) and I developed a terrible hacking cough (but it lowered my BP). Finally I couldn't stand it any more, was going through a bag of Halls a day and told the doc no more.
I know this is a long post and I apologize but would like to have an opinion on what others think I should do.
Generally the problem is using too small a cuff, with switching to a larger cuff resulting in a lower reading. The cuffs have markings to determine if they are the right size.Went through a recent physical exam for work and found out that the size of the cuff they wrap around your arm can also make a difference. I've never had an issue with HBP but when the nurse took the first reading it was much higher than normal and I told her so. She explained that the cuff size can make a difference and changed out the cuff with a narrower one, took my blood pressure again and it was normal. First time I ran into this, didn't even realize they had different sizes for patients.